View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Professor of Medicine
Director, Mount Sinai Liver Cancer Program
Division of Liver Diseases
Mount Sinai School of Medicine
Professor of Research
Liver Unit, IDIBAPS
Hospital Clínic Barcelona
Barcelona, Spain
Professor of Medicine
Medical University of Vienna
Vienna, Austria
Department Chair
Innere Medizin und Gastroenterologie
Klinikum Klagenfurt am Wörthersee
Klagenfurt am Wörthersee, Austria
This program has been made available online.
Downloadable slideset with highlights from key gastrointestinal cancers as presented at 2022 ESMO World Congress on Gastrointestinal Cancer, from Clinical Care Options (CCO)
Patient-reported outcomes from the HIMALAYA study of durvalumab with or without tremelimumab vs sorafenib in unresectable hepatocellular carcinoma, presented at ASCO 2022 and reported by Clinical Care Options (CCO)
Experts highlight key studies being presented at the 2022 ASCO Annual Meeting in this commentary from Clinical Care Options (CCO)
Allison Betof Warner, MD, PhD
John M. Burke, MD
Shaji K. Kumar, MD
Christopher H. Lieu, MD
Stephen V. Liu, MD
Joyce O'Shaughnessy, MD
Zofia Piotrowska, MD, MHS
Angeles Alvarez Secord, MD, MHSc
Rachna Shroff, MD
Hussein Tawbi, MD, PhD
Eunice S. Wang, MD
Released: June 1, 2022
Clinical Care Options (CCO): Experts review key data for gastric, rectal, liver, hepatobiliary tract, and pancreas cancers from the 2022 ASCO Gastrointestinal Cancers Symposium and the ASCO Plenary Series
Manish A. Shah, MD
Rachna Shroff, MD
Physicians:
maximum of 1.0 AMA PRA Category 1 Credit™
Released: April 20, 2022
Expired:
April 19, 2023
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.